Free tool
FAERS Monitor: Zonegran
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020789 or its brand name (Zonegran, Zonisamide). Reports on generic versions are filed under their own applications.
Reports
14,830
Serious
11,239
76% of reports
Hospitalization
4,583
Death reported
894
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective1,707
- seizure1,667
- off label use953
- fatigue731
- somnolence688
- convulsion622
- dizziness584
- nausea581
- headache569
- fall521
- drug interaction482
- condition aggravated465
- vomiting452
- diarrhoea423
- epilepsy408
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 166 |
| 2005 | 182 |
| 2006 | 245 |
| 2007 | 236 |
| 2008 | 268 |
| 2009 | 305 |
| 2010 | 329 |
| 2011 | 490 |
| 2012 | 518 |
| 2013 | 446 |
| 2014 | 547 |
| 2015 | 777 |
| 2016 | 937 |
| 2017 | 706 |
| 2018 | 891 |
| 2019 | 1,058 |
| 2020 | 929 |
| 2021 | 1,148 |
| 2022 | 1,093 |
| 2023 | 1,023 |
| 2024 | 969 |
| 2025 | 946 |
| 2026 | 621 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,039,329 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| seizureSignal | 1,667 | 20.8 | 19.8 | 31,041 |
| epilepsySignal | 408 | 19.2 | 17.4 | 6,925 |
| convulsionSignal | 622 | 15.6 | 14.4 | 8,406 |
| somnolenceSignal | 688 | 4.9 | 4.5 | 2,118 |
| drug interactionSignal | 482 | 4.3 | 4.0 | 1,232 |
| fallSignal | 521 | 2.2 | 2.0 | 354 |
| condition aggravatedSignal | 465 | 2.2 | 2.0 | 296 |
| drug ineffective | 1,707 | 1.8 | 1.8 | 694 |
| dizziness | 584 | 1.7 | 1.5 | 157 |
| off label use | 953 | 1.5 | 1.5 | 190 |
| vomiting | 452 | 1.4 | 1.2 | 44 |
| fatigue | 731 | 1.3 | 1.2 | 62 |
| headache | 569 | 1.3 | 1.2 | 37 |
| nausea | 581 | 1.0 | 1.0 | 1 |
| diarrhoea | 423 | 0.9 | 0.8 | 2 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.